Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people starting Wegovy (semaglutide) wonder whether taking a probiotic at the same time could ease gut side effects or improve results. The honest answer is that research on probiotics alongside GLP-1 medicines is still early, but there are sensible, evidence-grounded reasons why some clinicians think gut health is worth paying attention to on treatment. Wegovy is a prescription-only medicine requiring clinical assessment; a prescriber decides whether it is suitable for you and can discuss any supplements alongside it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors in the brain and gut, reducing appetite and slowing the rate at which food moves through the stomach. That slower gastric emptying is useful for reducing hunger, but it also changes the gut environment substantially. Food sits in the digestive tract longer, which alters fermentation patterns and the bacterial balance in the large intestine. For some people this shows up quickly as nausea, bloating or changes in bowel habit; for others the adjustment is mild.
The NHS medicines page for semaglutide lists nausea, diarrhoea, constipation and indigestion among the most commonly reported effects, particularly in the first weeks after starting or after a dose step-up. These effects usually settle as the body adjusts. That context matters when thinking about probiotics, because any supplement that also targets gut bacterial balance is working in an environment that semaglutide is actively reshaping.
This is why the question of whether you can take probiotics with Wegovy is more nuanced than a simple yes or no. It is not about safety in the conventional sense (there is no known direct interaction between probiotic supplements and semaglutide) but about timing, purpose and realistic expectations.
Dedicated clinical trials examining probiotics alongside semaglutide for weight management are thin on the ground. What exists is a broader body of research on gut microbiome changes in obesity and the role of bacterial diversity in metabolic health, plus a smaller set of studies looking at GLP-1 therapy and the microbiome in diabetes contexts. Taken together, this suggests that people living with obesity often have reduced microbial diversity, and that effective weight loss (regardless of how it is achieved) tends to shift the microbiome in a more favourable direction.
Whether supplementing with probiotics accelerates or enhances that shift during Wegovy treatment is genuinely unknown. Some researchers hypothesise that supporting the gut lining during the adjustment period may reduce the severity of GI side effects, but robust randomised controlled trial evidence for this specific combination does not yet exist. The clinical trial data on Wegovy's weight-loss outcomes comes from the STEP programme, which did not examine probiotic co-supplementation.
If you are researching which strains are most discussed in this context, a look at the evidence around probiotic choices alongside semaglutide is worth your time. Strains from the Lactobacillus and Bifidobacterium families appear most in the literature, though strain-specific evidence for GLP-1 co-use remains limited. Realistic expectations are important here: a probiotic is unlikely to meaningfully alter your weight-loss results on Wegovy, but it may support gut comfort during the adjustment phase.
Timing a probiotic around Wegovy injections is less complex than it sounds. Wegovy is a once-weekly injection, so there is no daily oral dosing to coordinate. The practical consideration is that because gastric emptying slows on treatment, supplements taken by mouth may spend longer in the stomach. Most probiotic capsules are designed to survive stomach acid regardless, so this is unlikely to matter significantly, but taking your probiotic at a consistent time each day (many people find first thing in the morning works, before the kettle has even finished boiling) supports a regular habit and avoids the nausea window that sometimes follows meals early in treatment.
Antibiotics are a separate issue. If you need a course of antibiotics while on Wegovy, most microbiome-aware clinicians recommend spacing a probiotic two hours away from each antibiotic dose; you can read more about managing Wegovy alongside antibiotics in detail. Hair-related supplements like biotin sometimes come up in this conversation too, because some patients notice hair thinning in significant weight-loss periods. The evidence on biotin and Wegovy is a distinct topic, but the same principle applies: discuss any new supplement with your prescriber before starting.
For a broader view of how Wegovy works and what it is licensed for in the UK, the Wegovy treatment page covers the essentials clearly, and the NHS England guidance on weight-management injections addresses lifestyle considerations including supplements in the context of wraparound care.
If nausea or bowel changes are affecting your day-to-day life in the early weeks of treatment, the first call is to your prescriber, not the supplement aisle. Dose titration exists partly for this reason: starting at 0.25mg and stepping up slowly gives the gut time to adapt. Rushing the schedule is one of the more common reasons GI side effects become unmanageable. Adequate hydration, smaller meals and reducing high-fat foods all have more evidence behind them for GI symptom management on GLP-1 therapy than probiotics currently do.
Probiotics are not harmful in this context, and if you already take one regularly there is no strong reason to stop. But treating them as a fix for persistent or severe symptoms is not the right approach. Severe stomach pain, particularly pain that moves towards the back, warrants urgent medical assessment, the MHRA has specifically highlighted acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines. You can report any suspected side effects at the MHRA's Yellow Card scheme.
Our prescribers at the weight-loss treatment overview take exactly these kinds of questions seriously. If you are thinking about starting Wegovy and want to talk through supplements, gut health or anything else relevant to your situation, you are welcome to speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.